Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Mach7 Technologies ( (AU:M7T) ) has provided an update.
Mach7 Technologies Limited announced an update on its ongoing share buy-back program, with a total of 5,770,000 securities bought back before the previous day and an additional 120,000 securities acquired on the previous day. This buy-back initiative is part of the company’s strategy to optimize its capital structure, potentially enhancing shareholder value and reinforcing its market position.
The most recent analyst rating on (AU:M7T) stock is a Buy with a A$0.95 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies Limited operates in the technology industry, focusing on providing innovative healthcare solutions. The company specializes in developing and delivering enterprise imaging platforms that facilitate medical data management and sharing, enhancing the efficiency and effectiveness of healthcare services.
YTD Price Performance: -13.75%
Average Trading Volume: 255,346
Technical Sentiment Signal: Sell
Current Market Cap: A$83.23M
Find detailed analytics on M7T stock on TipRanks’ Stock Analysis page.